Cargando…
Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer
Increased detection of plasma lysophosphatidic acid (LPA) has been proposed as a potential diagnostic biomarker in ovarian cancer, but inconsistency exists in these reports. It has been shown that LPA can undergo an artificial increase during sample processing and analysis, which has not been accoun...
Autores principales: | Yagi, Tsukasa, Shoaib, Muhammad, Kuschner, Cyrus E., Nishikimi, Mitsuaki, Becker, Lance B., Lee, Annette T., Kim, Junhwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521627/ https://www.ncbi.nlm.nih.gov/pubmed/30979045 http://dx.doi.org/10.3390/cancers11040520 |
Ejemplares similares
-
Relative Ratios Enhance the Diagnostic Power of Phospholipids in Distinguishing Benign and Cancerous Ovarian Masses
por: Yagi, Tsukasa, et al.
Publicado: (2019) -
Plasma metabolomics supports the use of long-duration cardiac arrest rodent model to study human disease by demonstrating similar metabolic alterations
por: Shoaib, Muhammad, et al.
Publicado: (2020) -
Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies
por: Hayashida, Kei, et al.
Publicado: (2021) -
Exogenous mitochondrial transplantation improves survival and neurological outcomes after resuscitation from cardiac arrest
por: Hayashida, Kei, et al.
Publicado: (2023) -
Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
por: De La Franier, Brian, et al.
Publicado: (2020)